Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy.
Ritch
P S
PS
Medical College of Wisconsin, Milwaukee, USA.
Keever
C
C
Schiller
J
J
Rivkin
S
S
Witt
P L
PL
Grossberg
S E
SE
Truitt
R L
RL
Burris
H
H
von Hoff
D D
DD
Vaickus
L
L
D000970:Antineoplastic Agents / Q000008:administration & dosage; D004334:Drug Administration Schedule; D006031:Glycosylation; D006801:Humans; D015850:Interleukin-6 / Q000008:administration & dosage* / Q000737:chemistry; D009369:Neoplasms / Q000188:drug therapy*; D011994:Recombinant Proteins
D000970:Antineoplastic Agents; D015850:Interleukin-6; D011994:Recombinant Proteins